Sera Prognostics Inc. (SERA)
4.29
0.04 (0.94%)
At close: Feb 20, 2025, 3:59 PM
4.27
-0.47%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 4.17 |
| Market Cap | 146.09M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -4.33 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 4.75 |
| Volume | 118,674 |
| Avg. Volume (20D) | 125,757 |
| Open | 4.25 |
| Previous Close | 4.25 |
| Day's Range | 4.18 - 4.46 |
| 52-Week Range | 3.84 - 12.36 |
| Beta | undefined |
About SERA
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, g...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 15, 2021
Employees 55
Stock Exchange NASDAQ
Ticker Symbol SERA
Website https://seraprognostics.com
Analyst Forecast
According to 1 analyst ratings, the average rating for SERA stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Sera Prognostics Inc. is scheduled to release its earnings on Mar 19, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-9.44%
Sera Prognostics shares are trading lower after th...
Unlock content with
Pro Subscription
